Simulations Plus, Inc. · NASDAQ:SLP
Simulations Plus — Q4 FY2019 Earnings Presentation
20 slides from Simulations Plus's earnings presentation, Nov 14, 2019
Slide 1: Q4FY2019 Investor Conference Call
Q4FY2019 Investor Conference Call Shawn O’Connor, CEO John Kneisel, CFO November 13, 2019 (NASDAQ:SLP)
Slide 2: Safe Harbor Statement
2 With the exception of historical information, the matters discussed in this presentation are forward - looking statements that involve a number of risks and uncertainties . The actual results of the Company could differ significantly from those statements . Factors that could cause or contribute t
Slide 3: Highlights
Highlights • Strong revenue growth for the quarter and full year – 15% growth for the full year at high end of historical 10 - 15% range and comparable to 10% organic growth last year – 20% growth for the quarter reflects goal of moving to 15 - 20% consistent range • Software business steady consist
Slide 4: Steady and Consistent Revenue Growth
Steady and Consistent Revenue Growth 4 Organic Revenue Growth accelerating to new 15 - 20% range $13.8 $14.9 $16.9 $18.5 $6.1 $9.2 $12.8 $15.5 $19.9 $24.1 $29.7 $34.0 2016 2017 2018 2019 12 Months Revenue $ in millions Software Consulting Key Highlights • Q4 FY2019 Financial Highlights – Revenue up
Slide 5: Simulations Plus Division (Lancaster)
Simulations Plus Division (Lancaster) 5 The genesis of the company… providing software, training and consulting services $13.6 $14.5 $15.7 $17.3 $0.9 $1.1 $1.8 $2.3 $14.5 $15.6 $17.5 $19.6 2016 2017 2018 2019 12 Months Revenue $ in millions Software Consulting Simulations Plus represented 52% of tot
Slide 6: Cognigen Division (Buffalo)
Key Highlights • Q4 FY2019 Financial Highlights – Revenue up 14% for the quarter and 19% for the year – 11 new projects initiated during quarter – 32 proposals outstanding with 23 companies at the start of 1QFY20 • Operational Highlights – Announced the promotion of Cognigen Founder to President of
Slide 7: DILIsym Division (RTP)
$1.0 $1.0 $3.3 $4.1 $4.3 $5.1 2018 2019 12 Months Revenue $ in millions Software Consulting DILIsym Division (RTP) 7 A leading provider of software products and services in QST and QSP Key Highlights • Q4 FY2019 Financial Highlights – Revenue up 13% for the quarter and 19% for the year – Revenue bre
Slide 8: Financial Results
Financial Results SimulationsPlus
Slide 9: Income Statement: 4QFY19 Versus 4QFY18
9 Income Statement: 4QFY19 Versus 4QFY18 (in millions) Lancaster Buffalo North Carolina FY19 FY18 Diff % chg Net sales $ 4.2 $ 2.4 $ 1.4 $ 8.0 $ 6.7 $ 1.3 20.0% Gross profit $ 3.4 $ 1.3 $ 1.1 $ 5.7 $ 4.6 $ 1.2 25.6% Gross profit margin 80.8% 53.1% 75.3% 71.5% 68.3% 3.2% 4.6% SG&A $ 1.9 $ 0.9 $ 0.4 $
Slide 10: Income Statement: FY19 Versus FY18
10 Income Statement: FY19 Versus FY18 (in millions) Lancaster Buffalo North Carolina FY19 FY18 Diff % chg Net sales $ 19.6 $ 9.3 $ 5.1 $ 34.0 $ 29.7 $ 4.3 14.5% Gross profit 16.3 5.0 3.7 24.9 21.7 3.3 15.1% Gross profit margin 83.3% 53.2% 72.7% 73.4% 73.1% 0.3% 0.5% SG&A $ 6.8 $ 3.4 $ 1.6 $ 11.8 9.6
Slide 11: Consolidated Revenues: Fiscal Quarter
11 Consolidated Revenues: Fiscal Quarter ( in millions) $4.0 $4.6 $5.9 $3.7 $4.8 $5.2 $6.0 $4.0 $5.4 $5.7 $6.8 $6.3 $7.1 $7.4 $8.6 $6.7 $7.5 $8.5 $9.9 $8.0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 $10 $11 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 12: Consolidated Income from Operations: Fiscal Quarter
12 Consolidated Income from Operations: Fiscal Quarter (in millions) $0.7 $1.5 $2.9 $0.8 $1.7 $1.7 $2.8 $1.0 $1.9 $1.8 $3.1 $1.4 $2.6 $2.4 $3.4 $1.9 $2.0 $2.7 $3.9 $2.1 $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 $4.5 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 13: Consolidated Net Income: Fiscal Quarter
$0.5 $1.0 $1.9 $0.5 $1.1 $1.2 $1.9 $0.8 $1.4 $1.2 $2.1 $1.2 $1.7 $3.5 $2.4 $1.3 $1.5 $2.1 $2.9 $2.1 $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019 $2.0 13 Note: 2Q18 $1.5M tax benefit of deferred tax adjustment Consolidated Net Income: Fiscal Quarter (in millions)
Slide 14: Consolidated Diluted Earnings Per Share: Fiscal Quarter
14 Consolidated Diluted Earnings Per Share: Fiscal Quarter $0.03 $0.06 $0.11 $0.03 $0.06 $0.07 $0.11 $0.05 $0.08 $0.07 $0.12 $0.06 $0.10 $0.19 $0.13 $0.07 $0.09 $0.12 $0.16 $0.11 $0.00 $0.02 $0.04 $0.06 $0.08 $0.10 $0.12 $0.14 $0.16 $0.18 $0.20 Q1 Q2 Q3 Q4 FY15 FY16 FY17 FY18 FY19 $0.11 Note: 2Q18 $
Slide 15: Consolidated EBITDA: Fiscal Quarter
15 Consolidated EBITDA: Fiscal Quarter (in millions) $1.2 $2.0 $3.3 $1.2 $2.2 $2.2 $3.3 $1.5 $2.5 $2.3 $3.6 $2.0 $3.2 $3.1 $4.1 $2.6 $2.8 $3.4 $4.6 $2.7 $0 $1 $2 $3 $4 $5 Q1 Q2 Q3 Q4 2015 2016 2017 2018 2019
Slide 16: Revenue by Region – YTD 2019
Revenue by Region – YTD 2019 Europe 18 % North America 64 % Asia 18 % South America <1% Japan = 55% India = 17% China = 17% Other = 11% 16 A global and diversified base of revenue
Slide 17: Cash Position Remains Excellent
17 Cash Position Remains Excellent (in millions) Over $30 million cash paid out over last five FYs $0.8 $0.8 $0.8 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $0.9 $1.0 $1.0 $1.0 $1.1 $1.1 $1.1 $1.1 $1.1 $2.1 $0.8 $0.7 $0.8 $1.0 $5.0 $1.6 $1.0 $1.7 $5.8 $6.1 $6.4 $8.6 $7.2 $7.1 $8.8 $8.0 $8.8 $7.4 $8.2 $
Slide 18: Selected Consolidated Balance Sheet Items
18 Selected Consolidated Balance Sheet Items (in millions, except where indicated) August 31, 2019 August 31, 2018 Cash and cash equivalents $ 11.4* $ 9.4* Cash per share ( in Dollars ) $ 0.65 $ 0.54 Total current assets 21.2 17.8 Total assets 45.2 43.3 Total current liabilities 4.8 4.8 Total liabil
Slide 19: Products & Services, Consistent Financial Results
1 No assurances can be made as the BOD makes its decision on a quarterly basis based on current financial condition and strateg ic plans Products & Services Software Portfolio • Modeling & simulation platform for drug R&D • Predictive software for >140 properties of chemical formulations • Analytica
Slide 20: Thank you!
20 Thank you! https://www.linkedin.com/company/simulations - plus https://www.linkedin.com/company/cognigen https://www.linkedin.com/company/dilisym